<!-- google_ad_section_start -->Study of Gastric Stimulator for Patients With Type 2 Diabetes Who areOverweight<!-- google_ad_section_end -->
Health Forums

Go Back   Health Forums > Diseases and Conditions > Diabetes > alt.support.diabetes

Reply
 
LinkBack Thread Tools Display Modes
  #1  
Old 12-01-2007, 10:47 PM
Kurt
Guest
 
Posts: n/a
Default Study of Gastric Stimulator for Patients With Type 2 Diabetes Who areOverweight

http://diabetes.org/diabetesnewsarti...ntalusEDIT.xml

or

http://tinyurl.com/yp38wg

(excerpt)

ADA Comments:
ORANGEBURG, N.Y., Nov 28, 2007 /PRNewswire via COMTEX/ -- MetaCure
Limited, today announced that it began patient enrollment in a
national diabetes clinical trial of its TANTALUS(R) System, an
investigational device being tested in patients with type 2 diabetes
who are overweight. The study is being conducted in up to 30 sites in
the United States. The 300-patient trial will evaluate the TANTALUS,
an implantable device that delivers electrical pulses to the stomach
when a person eats. The primary objective of the randomized, double-
blind controlled study is to evaluate the TANTALUS System in treating
patients who have type 2 diabetes
--------------------------------------------------------------------------------
28-NOV-2007

MetaCure(TM) Launches Investigational Study of Gastric Stimulator for
Patients With Type 2 Diabetes Who are Overweight-- First Patient
Implanted in San Antonio, TX -


ORANGEBURG, N.Y., Nov 28, 2007 /PRNewswire via COMTEX/ -- MetaCure
Limited, today announced that it began patient enrollment in a
national diabetes clinical trial of its TANTALUS(R) System, an
investigational device being tested in patients with type 2 diabetes
who are overweight. The study is being conducted in up to 30 sites in
the United States.

The 300-patient trial will evaluate the TANTALUS, an implantable
device that delivers electrical pulses to the stomach when a person
eats. The primary objective of the randomized, double-blind controlled
study is to evaluate the TANTALUS System in treating patients who have
type 2 diabetes and are overweight. Impact on blood glucose levels,
weight loss, blood pressure and other clinical and metabolic
parameters will be studied. To be considered for the trial, patients
must meet certain inclusion criteria, including a diagnosis of type 2
diabetes with a body mass index (BMI) between 28 and 45 kg/m2 and ages
18 to 70.

Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is Off
HTML code is Off
Trackbacks are On
Pingbacks are On
Refbacks are On
Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
Type 2 Diabetes Study allenxvr alt.support.diabetes 6 11-09-2007 09:18 PM
Type 2 Diabetes Study allenxvr alt.support.diabetes 3 10-24-2007 08:00 AM
Type 2 Diabetes Study ePS1092@gmail.com alt.support.diabetes 2 08-22-2007 12:06 AM
Type 2 Diabetes Study allenxvr alt.support.diabetes 0 06-19-2007 10:05 PM
The Effect of Pioglitazone on Recurrent Myocardial Infarction in 2,445 Patients With Type 2 Diabetes Ozgirl alt.support.diabetes 0 05-10-2007 04:14 AM


All times are GMT. The time now is 08:45 AM.


Powered by vBulletin® Version 3.7.2
Copyright ©2000 - 2008, Jelsoft Enterprises Ltd.
Search Engine Optimization by vBSEO 3.2.0
     
   
 

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41